Lannett Co

LCI NYSE
5.68
+0.04
+0.71%
盘后: 5.68 0 0.00% 16:25 06/25 EDT
开盘
5.71
昨收
5.64
最高
5.81
最低
5.50
成交量
64.67万
成交均量(3M)
113.70万
52周最高
14.70
52周最低
3.330
换手率
1.64%
市值
2.23亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Lannett Co LCI股票价格,Lannett Co股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Lannett Company, Inc. develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. The Company manufactures and/or distributes prescription products with the exception of a small portfolio of over-the-counter products manufactured by its subsidiary, Silarx Pharmaceuticals, Inc. As of June 30, 2016, the Company's products included Acetazolamide Tablets; Butalbital, Acetaminophen and Caffeine Tablets; Butalbital, Aspirin and Caffeine Capsules; C-Topical Solution; Digoxin Tablets; Glycolax Rx; Isosorbide Mononitrate CR; Levothyroxine Sodium Tablets; Methylphenidate HCL CD; Methylphenidate ER; Nifedipine CR; Omeprazole DR; Oxbutynin ER; Pantoprazole DR; Pilocarpine HCl Tablets; Triamterene w/Hydrochlorothiazide Capsules, and Ursodiol Capsules. The Company has additional products under development, which are orally administered solid oral-dosage products (tablet/capsule) or oral solutions, nasal, topicals or parentarels, as well as other dosage forms.
展开 >

最近浏览

名称
价格
涨跌幅